SPOTLIGHT: Organogenesis plans expansion


With the help of state funds, Organogenesis is beefing up its operations in Massachusetts. The company, which makes regenerative medicine products, says it was persuaded to stay and grow in Massachusetts because of the state's new program to encourage the biotech field. Release | Report

Suggested Articles

After teaming up with other Big Pharmas to bolster antibiotics research, Pfizer is adding a new antibiotic prospect to its pipeline.

The oral direct-acting antiviral is set to enter a phase 3 trial in non-hospitalized patients early next year.

RA Capital 's 15-month old inaugural venture fund that has already seen 25% of its portfolio companies IPO or be acquired.